Javascript must be enabled to continue!
Pharmacists’ naloxone offering and dispensing practices
View through CrossRef
Objective: The primary objective of this paper is to understand pharmacists’ naloxone offering and dispensing practices and factors affecting those practices. The secondary objective of this paper is to refine an existing survey instrument and use it to understand pharmacists’ naloxone offering and dispensing behaviors and factors affecting it.Design, settings, and participants: A statewide mail survey of pharmacists was conducted in Wisconsin using stratified random sampling. Survey data were analyzed using descriptive statistics to understand pharmacists’ naloxone offering and dispensing practices and multiple regression analysis to understand factors affecting these practices.Main outcomes: (1) Pharmacists’ practices about naloxone offering and dispensing; (2) factors affecting these practices. Results: Most pharmacies stocked naloxone (92.9 percent) and were under the Wisconsin standing order (80.1 percent). The majority of pharmacists reported that they occasionally (36.6 percent), rarely (29.3 percent), or never (21.5 percent) offer naloxone to patients. The majority reported that they occasionally (29.3 percent), rarely (52.4 percent), or never (15.2 percent) dispense naloxone. While most pharmacists were confident in their ability to initiate conversations about naloxone, they were not confident on how to screen patients at risk for opioid overdose. Pharmacists offered naloxone more when they felt more confident initiating a conversation regarding the need for naloxone with patients (β = 0.50, p <0.05). Pharmacists dispensed naloxone more when they have had more previous training about dispensing naloxone (β = 0.43, p <0.05).Conclusion: Many pharmacists hardly offer or dispense naloxone under the standing order. Pharmacists may benefit from standardized training and resources about screening patients for risk of overdose and overdose risk communication.
Weston Medical Publishing
Title: Pharmacists’ naloxone offering and dispensing practices
Description:
Objective: The primary objective of this paper is to understand pharmacists’ naloxone offering and dispensing practices and factors affecting those practices.
The secondary objective of this paper is to refine an existing survey instrument and use it to understand pharmacists’ naloxone offering and dispensing behaviors and factors affecting it.
Design, settings, and participants: A statewide mail survey of pharmacists was conducted in Wisconsin using stratified random sampling.
Survey data were analyzed using descriptive statistics to understand pharmacists’ naloxone offering and dispensing practices and multiple regression analysis to understand factors affecting these practices.
Main outcomes: (1) Pharmacists’ practices about naloxone offering and dispensing; (2) factors affecting these practices.
Results: Most pharmacies stocked naloxone (92.
9 percent) and were under the Wisconsin standing order (80.
1 percent).
The majority of pharmacists reported that they occasionally (36.
6 percent), rarely (29.
3 percent), or never (21.
5 percent) offer naloxone to patients.
The majority reported that they occasionally (29.
3 percent), rarely (52.
4 percent), or never (15.
2 percent) dispense naloxone.
While most pharmacists were confident in their ability to initiate conversations about naloxone, they were not confident on how to screen patients at risk for opioid overdose.
Pharmacists offered naloxone more when they felt more confident initiating a conversation regarding the need for naloxone with patients (β = 0.
50, p <0.
05).
Pharmacists dispensed naloxone more when they have had more previous training about dispensing naloxone (β = 0.
43, p <0.
05).
Conclusion: Many pharmacists hardly offer or dispense naloxone under the standing order.
Pharmacists may benefit from standardized training and resources about screening patients for risk of overdose and overdose risk communication.
Related Results
Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Abstract
Patients with sickle cell disease (SCD) are known to require increased dosing of drugs including opioids due to differences in renal and hepatic metabolism....
Naloxone Knowledge, Carrying, Purchase, and Use
Naloxone Knowledge, Carrying, Purchase, and Use
ImportanceWidespread naloxone access is a key policy response to the opioid crisis. Naloxone availability is typically estimated from pharmacy sales, which exclude naloxone provide...
Naloxone Improves Splanchnic Perfusion in Conscious Dogs through Effects on the Central Nervous System
Naloxone Improves Splanchnic Perfusion in Conscious Dogs through Effects on the Central Nervous System
Background
In patients undergoing colonoscopy, naloxone has vasodilative properties. However, it remains unclear whether this effect is mediated by central or p...
Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users
Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users
Objective: To assess the reduction in intravenous (IV) abuse potential of hydromorphone from different dose ratio combinations with naloxone in opioid-dependent drug users.Design: ...
Improving harm reduction with a naloxone intervention in primary care to prescribe and educate a support person
Improving harm reduction with a naloxone intervention in primary care to prescribe and educate a support person
Objective: To determine whether a pharmacist-led intervention would increase the number of naloxone prescriptions and naloxone administration education in a primary care family med...
A Nation-Wide Assessment of Community Pharmacists’ Attitude towards Dispensing Medication Errors: A Cross-sectional Study
A Nation-Wide Assessment of Community Pharmacists’ Attitude towards Dispensing Medication Errors: A Cross-sectional Study
Dispensing errors in community pharmacies are common reasons for a
patient’s injury and harm. Therefore, to improve patient safety in
relation to the use of medicine in the primary...
Assessment of Pharmacists’ Knowledge and Practices towards Prescribed Medications for Dialysis Patients at a Tertiary Hospital in Riyadh Saudi Arabia
Assessment of Pharmacists’ Knowledge and Practices towards Prescribed Medications for Dialysis Patients at a Tertiary Hospital in Riyadh Saudi Arabia
Objective: The present study examined pharmacists’ knowledge and practices towards prescribed medications for hemodialysis patients. The impact of a pharmacist’s current positions ...
Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: A meta-analysis
Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: A meta-analysis
Objectives: Pruritus may be a significant problem for patients in the postoperative period. There are many options for the treatment of pruritus including intravenous (IV) naloxone...

